Bordetella pertussis, an aerobic gram-negative rod, is the causative agent of whooping cough (pertussis) in humans. Pertussis is a highly contagious disease involving the respiratory tract and is especially dangerous for infants and young children. Increasing numbers of adolescents and adults with pertussis have also been reported (15) . Widespread immunization has drastically reduced the prevalence of pertussis in many countries; however, outbreaks still occur even in well-immunized communities (13) .
The main virulence factors of B. pertussis comprise surface adhesion molecules that are responsible for attachment of the bacteria to host cells (filamentous hemagglutinin, fimbriae, pertactin) and toxins that facilitate evasion of the host immune system by the bacterium (pertussis toxin, adenylate cyclase toxin, dermonecrotic toxin, tracheal cytotoxin) (43) .
One of the virulence determinants of B. pertussis and the most abundant surface molecule is lipopolysaccharide (39) . This molecule plays a major role in the host-pathogen interactions (46) and is responsible for endotoxic activities similar to those of enteric bacteria (1, 50) . (4) , which consist of a lipid A moiety linked to a core nonasaccharide or a dodecasaccharide. The LPS of B. pertussis is devoid of an O-specific polysaccharide chain; instead, it contains a single distal trisaccharide and thus structurally is a lipooligosaccharide.
B. pertussis produces only two types of LPS
Although whole-cell pertussis vaccines are effective in controlling whooping cough, concerns related to adverse effects following vaccination have led to the development of acellular pertussis vaccines composed of different surface proteins (filamentous hemagglutinin, pertactin, fimbriae 2 and 3, inactivated pertussis toxin) in various combinations. Two-and fivecomponent acellular vaccines have been shown to protect against pertussis with 58% and 85% efficacy, respectively (12) . Despite the high vaccination coverage in some countries (e.g., The Netherlands, Australia, and Canada) (33) , a substantial increase in the incidence of pertussis has been observed in the last few decades (6, 47) .
There are conflicting data regarding the role of LOS in protection against whooping cough. It was found that most of the sera obtained from children with diagnosed pertussis, as well as sera from children vaccinated with a whole-cell pertussis vaccine, contained specific anti-LOS antibodies, suggesting that LOS present on B. pertussis cells is immunogenic. On the other hand, in an animal model of B. pertussis infection, anti-LOS antibodies did not protect against a subsequent challenge with virulent bacteria. However, the lack of an immune re-sponse against LOS in this experiment was probably due to the inappropriate form of antigen and the route of administration (5) .
The biological activities of B. pertussis LOS are similar to those of endotoxins isolated from other gram-negative bacteria. It has been shown that LOS of B. pertussis is an antigen in natural infection (44) , and new findings suggest that it is an important etiological factor in whooping cough pathogenesis and is directly involved in destruction of the ciliated cells of the human airways mucosa (8) . LOS, working synergistically with tracheal cytotoxin, takes part in induction of nitric oxide synthase in nonciliated epithelial cells, and this is followed by NO release and subsequent damage to the ciliated cells (8, 9) .
The importance of the B. pertussis endotoxin as a virulence factor is further indicated by its involvement in the interaction with SP-A of the respiratory tract (41) . SP-A binds to gramnegative microorganisms via lipid A, inducing destabilization of bacterial membranes, and it plays an important role in innate immunity. Surprisingly, it was found that SP-A neither bound nor permeabilized wild-type B. pertussis cells. The lack of a bactericidal effect of SP-A on B. pertussis was explained by the presence of the trisaccharide at the nonreducing end of the LOS core oligosaccharide, which hindered access of the protein to the lipid A (41). Previously, it has also been demonstrated that a mouse monoclonal antibody specific for the dodecasaccharide-containing LOS of B. pertussis has complement-dependent bactericidal activity and substantially reduces colonization of the respiratory tract of mice following aerosol infection (35) . These data further suggest that epitopes specific for the trisaccharide in the LOS of B. pertussis are involved in complement-dependent bactericidal activity.
As LOS is also the most abundant cell surface component of B. pertussis, it was of interest to evaluate LOS epitopes as a target for antibodies that might be protective against biological activities of B. pertussis. For these experiments we used the LOS of B. pertussis strain 186, a wild-type strain and a component of the whole-cell pertussis vaccine which has been used in Poland since 1978 (53) . The vaccine also contains strains 606 and 629. So far, data on the structural details of LOS isolated from a single strain, strain 1414, have been published (3) .
Thus, here we describe structural details of the B. pertussis strain 186 LOS and the antiendotoxin activity of polyclonal antibodies against a covalent conjugate of the pentasaccharide with tetanus toxoid (17) . We also performed STD NMR experiments for identification of the binding epitope in the pentasaccharide investigated. Additionally, by using HR-MAS NMR analysis, we were also able to identify the pentasaccharide directly on intact LOS and to distinguish the LOS of B. pertussis strain 186 from the LOS of strain 606.
MATERIALS AND METHODS

Abbreviations.
The following abbreviations are used in this paper: LPS, lipopolysaccharide; LOS, lipooligosaccharide; SP-A, surfactant protein A; TT, tetanus toxoid; PBS, phosphate-buffered saline; MALDI-TOF, matrix-assisted laser desorption ionization-time of flight; MS, mass spectrometry; PAGE, polyacrylamide gel electrophoresis; FACS, fluorescence-activated cell sorter; NMR, nuclear magnetic resonance; COSY, correlated spectroscopy; TOCSY, total correlation spectroscopy; ROESY, rotating frame nuclear Overhauser effect spectroscopy; HMBC, heteronuclear multiple bond correlation; HSQC, heteronuclear single quantum coherence; DEPT, distortionless enhancement by polarization transfer; HR-MAS, high-resolution magic angle spinning; STD, saturation transfer difference; TNF-␣, tumor necrosis factor alpha; FBS, fetal bovine serum; SDS, sodium dodecyl sulfate; IgG, immunoglobulin G; ELISA, enzymelinked immunosorbent assay; IL-6, interleukin-6; LD-Hep, L-glycero-D-mannoheptose; D-ManpNAc3NAcA, 2,3-diacetamido-2,3-dideoxy-mannuronic acid; L-FucNAc4NMe, 2-acetamido-4-N-methyl-2,4,6-trideoxy-galactose; 2,5-anhydroMan, 2,5-anhydro-D-mannose; MTT, 1-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
Bacteria. B. pertussis strains 186 and 606, which are used by Biomed, Krakow, Poland, for production of pertussis vaccine, and two clinical isolates, strains 3210 and 3225 (National Institute of Public Health, Warsaw, Poland), were used in this study. The bacteria were grown on Bordet-Gengou medium and solidified Cohen-Wheeler charcoal-containing medium, collected as a suspension in PBS, and killed by incubation at 60°C for 45 min.
Cell lines. Cells of mouse macrophage-like cell line J774A.1 were obtained from the German Collection of Microorganisms and Cell Cultures (Braunschweig, Germany), and TNF-␣-sensitive WEHI 164 clone 13 mouse fibrosarcoma cells were kindly donated by M. Zimecki (Institute of Immunology and Experimental Therapy, Wroclaw, Poland). J774A.1 cells were grown in Dulbecco's medium supplemented with 10% FBS (Gibco, Biocult, Glasgow, United Kingdom). WEHI 164.13 cells were grown in RPMI 1640 medium supplemented with 10% FBS, 2 mM L-glutamine, 1 mM pyruvic acid, and 4 mM 2-mercaptoethanol. Cells were grown and maintained during the tests at 37°C in the presence of 5% CO 2 .
Preparation of lipooligosaccharide of B. pertussis strain 186 and isolation of the pentasaccharide. LOS was extracted from bacterial cells by the hot phenolwater method (52) and was purified by ultracentrifugation as previously described (36) . The pentasaccharide was selectively cleaved from the LOS of B. pertussis strain 186 by treatment with nitrous acid (22) . Briefly, the lipooligosaccharide (50 mg) was suspended in a freshly prepared solution (180 ml) containing water, 5% sodium nitrite, and 30% acetic acid (1:1:1, vol/vol/vol) and incubated for 4 h at 25°C, and this was followed by ultracentrifugation (200,000 ϫ g, 2 h). The supernatant was freeze-dried, and the product was purified on a column of Bio-Gel P-2 (Bio-Rad), yielding ϳ10 mg, and analyzed by MALDI-TOF MS and NMR spectroscopy.
Conjugation of the isolated pentasaccharide with tetanus toxoid. A conjugate was prepared by the method of Jennings and Lugowski (17) . A tetanus toxoid preparation was obtained from Biomed, Krakow, Poland. The pentasaccharide of B. pertussis strain 186 (10 mg) was dissolved in 1 ml of 0.5 M K 2 HPO 4 , pH 9.0. Tetanus toxoid (2.5 mg), NaBH 3 CN (10 mg), and 1 drop of chloroform were added to the solution. The reaction mixture was kept in a sealed vial for 12 days at 37°C and then applied to a Sephadex G-100 column (1.6 by 100 cm) equilibrated with PBS. Three batches of the conjugate were prepared. Fractions containing the conjugate were concentrated by ultrafiltration to obtain 2.5 mg of product. The calculated molar ratio of the pentasaccharide to tetanus toxoid obtained from a carbohydrate and protein determination was 8:1 to 10:1.
Mass spectrometry. MALDI-TOF MS of the oligosaccharide investigated, in the positive or negative mode, was performed with a Bruker Reflex III instrument. 2,5-Dihydroxybenzoic acid was used as the matrix.
NMR spectroscopy. NMR spectra of the isolated oligosaccharide were obtained for 2 H 2 O solutions at 40°C with a Bruker DRX 600 spectrometer, using acetone (␦ H 2.225 and ␦ C 31.05) as the internal reference. The oligosaccharide was repeatedly exchanged with 2 H 2 O with intermediate lyophilization prior to analysis. The signals were assigned by one-and two-dimensional experiments (COSY, clean-TOCSY, ROESY, HMBC, and HSQC-DEPT with and without carbon decoupling). In the clean-TOCSY experiments the mixing times were 30, 60, and 100 ms. The delay in the HMBC experiments and the mixing time in the ROESY experiments were 60 and 200 ms, respectively. The data were acquired and processed using standard Bruker software. The processed spectra were assigned with help of the SPARKY program (10) .
An analysis of pH dependence of the N-methyl resonance in the isolated pentasaccharide was carried out in 10% 2 H 2 O by using a pH range of 2 to 11, with the pH adjusted with 1 M HCl and 1 M NaOH. Spectra were obtained at 30°C with the WATERGATE (37) pulse program.
NMR spectra of suspensions of B. pertussis strains 186 and 606 LOS (ϳ0.5 mg) in 2 H 2 O (ϳ10 l) were obtained using the HR-MAS technique with a Bruker DRX 600 spectrometer. The experiments were carried out at a spin rate of 5 kHz at 23°C (the measured temperature of the pressurized air used for sample spinning) using a Bruker 4-mm HR-MAS probe and a ZrO 2 rotor. The onedimensional 1 H NMR spectra of the LOS were acquired using a Carr-PurcellMeibom-Gill pulse sequence 90-(-180-) n (31) as a T 2 filter before acquisition to reduce the broad signals of lipids (16) . The total delay time was 12 ms. The data were acquired and processed using standard Bruker software.
One-dimensional STD NMR experiments were performed at 37°C with a 7382 NIEDZIELA ET AL. INFECT. IMMUN.
2.5-mm inverse-detection probe head equipped with z-gradient. Spectra were recorded at 37°C using the pulse programs described previously (29) . The WA-TERGATE pulse sequence was used to suppress water signals in the spectra, and the broad resonances of a protein were suppressed with a 10-ms spin-lock pulse. The protein was irradiated at ␦ H Ϫ2.5 ppm (on-resonance) and ␦ H 40 ppm (off-resonance) with a train of n Gaussian shaped pulses (50 ms) separated by 20-s delays, and the saturated spectrum was subtracted from the reference via phase cycling. The setup of the STD NMR experiments was optimized in a series of experiments with ligand-protein and ligand-only samples to ensure that the irradiation at the selected frequency did not affect the ligand. The overall saturation time (0.1 to 3 s) was controlled with different values of n. The relaxation delay used in all the experiments was 0.5 s. Samples (total volume, 35 l) were prepared in PBS made with 2 H 2 O, pH 7.5 (not corrected for 2 H 2 O). Analytical procedures, immunizations, and polyclonal antibodies. The LOS were analyzed by SDS-PAGE using the method of Laemmli (21) with modifications described previously (40); a 17.5% (wt/vol) polyacrylamide-bisacrylamide gel was used as the separating gel, and a cathode buffer containing Tricine was used as described previously (23) . The LOS bands were visualized by the silver staining method (45) .
Four Belgian Giant rabbits were immunized with the B. pertussis pentasaccharide-TT conjugate suspended in complete Freund's adjuvant, and polyclonal antibodies against the conjugate were obtained by the procedures described previously (27) . Additionally, polyclonal antibodies against whole bacterial cells were obtained by intravenous immunization of four Belgian Giant rabbits with a PBS suspension of B. pertussis strains 186 and 606 (27) . Rabbits were housed at the animal facility of the Institute of Immunology and Experimental Therapy, Wroclaw, Poland, and all the experiments were carried out by using procedures approved by the Local Ethical Commission for Animal Experimentation.
As antisera give complex 1 H NMR spectra, containing signals of proteins, lipoproteins, and lipids, as well as low-molecular-weight metabolites that can interfere with the signals of ligand in the spectra during the STD NMR experiments, a crude ammonium sulfate-cut IgG-enriched fraction was prepared. Briefly, antiserum (550 l) was centrifuged (3,000 ϫ g, 15 min, 4°C) to remove any insoluble particles. A saturated ammonium sulfate solution (450 l) was added to the supernatant collected (final saturation, 45% [vol/vol]) and left overnight at 4°C. The mixture was then centrifuged, the supernatant was discarded, and the pellet was dissolved in PBS. The solution was dialyzed against PBS, using Microcon YM-50 filters with a 50-kDa cutoff (Millipore, Bedford, Mass.). The immunoglobulin fraction isolated was tested with an ELISA. The protein concentration was estimated and adjusted to 14 ⌴ by using UV absorbance at 280 nm. As no titration experiments were performed, the estimates were used for calculation of the approximate ligand-to-protein ratio (ratio of pentasaccharide to antibody binding sites, 140:1).
Immunofluorescence procedures and serological methods. Bacteria, cultured as described above, were washed and suspended in PBS to an optical density at 600 nm of 0.6 (4 ϫ 10 8 CFU/ml). Appropriate antisera (0.5 ml, 1/50 and 1/200 dilutions) were added to the bacterial suspension and incubated at 25°C for 2 h. Preimmune sera were employed as negative controls. Bacteria were washed three times with PBS and incubated with fluorescein isothiocyanate-labeled goat antirabbit IgG (3 h, 25°C). After thorough washing with PBS, bacteria were resuspended in PBS containing 0.5% paraformaldehyde. An analysis of the fluorescein isothiocyanate-labeled bacteria was performed using a FACSscan (Becton Dickinson) fluorescence-activated cell sorter. In each analysis 4 ϫ 10 4 bacterial cells were evaluated. Narrow-angle forward light scatter and green fluorescence emission signals were collected. Bacterial aggregates were electronically excluded on the basis of light scatter signals.
An ELISA, using LOS as the solid-phase antigen, was performed by a modification (17) of the method described by Voller et al. (49) , and immunoblotting was performed as previously described (36) . The detection systems consisted of a goat anti-rabbit IgG conjugated with alkaline phosphatase (Bio-Rad) as a second antibody and p-nitrophenylphosphate and 5-bromo-4-chloro-3-indolylphosphate-nitroblue tetrazolium for the ELISA and immunoblotting, respectively.
A quantitative microprecipitin test was carried out by the method of Kabat and Mayer (19) . The reaction mixture contained 2% polyethylene glycol 6000 to enhance the rate of immunoaggregate formation (38) .
Stimulation of TNF-␣, IL-6 release, and NO production in J774A.1 cells. J774A.1 cells were plated in 24-well tissue culture plates (Nunc, Denmark) at a concentration of 1 ϫ 10 6 cells/well in 1 ml of Dulbecco's medium supplemented with 10% (vol/vol) FBS, incubated for 2 h, and washed three times with serumfree medium. The cells were then incubated with serial dilutions of stimulants in the medium (total volume, 1 ml). The supernatants were collected after 6, 24, and 48 h for determination of TNF-␣, IL-6, and NO, respectively, and stored at Ϫ80°C until measurements were obtained.
TNF-␣ bioassay. TNF-␣ activity was determined by a cytotoxic assay using WEHI 164 clone 13 cells seeded at a concentration of 2 ϫ 10 4 cells/well in 96-well plates (Nunc, Denmark) in the presence of actinomycin D (1 g/ml), as previously described (7, 26) . The viability of the cells was determined by quantitative colorimetric staining with MTT as described by Mossmann (34), using 20% SDS with 50% dimethylformamide, pH 4.7 (100 l), as the extraction buffer according to the modification described by Hansen et al. (14) . The amount of TNF-␣ released upon stimulation was interpolated from the calibration curve obtained for murine recombinant TNF-␣ (PharMingen, San Diego, Calif.). The detection limit of the WEHI 164.13 cytotoxicity assay was 0.15 pg/ml.
IL-6 assays. The IL-6 content of the culture medium was quantified using a commercially available ELISA kit, an OptEIA mouse IL-6 set (PharMingen, San Diego, Calif.). The assay was performed according to the manufacturer's instructions. Recombinant mouse IL-6 was used as a standard. The dilutions of the samples tested were adjusted to the working range of the test (i.e., 15.6 to 1,000 pg/ml).
NO determination. The NO contents in the supernatants collected from stimulated J774A.1 cells were determined as the total nitrite (42), using the colorimetric assay with the Griess reagent described previously (11) .
Inhibition of TNF-␣, IL-6 release, and NO production in J774.1 cells. Appropriate antisera, including anti-B. pertussis pentasaccharide-TT conjugate serum, anti-whole-bacterium serum, and serum of a nonimmunized rabbit (100 l), were preincubated with B. pertussis 186 LOS (10 ng) for 1 h at 37°C, followed by transfer to a culture and incubation as described above. Serum of nonimmunized rabbits was used as a control. Samples (100 l) of the supernatants were collected after 6, 24, and 48 h and assayed for TNF-␣, IL-6, and NO release as described above.
Statistical analysis. A one-way analysis of variance test was used to analyze the significance of differences in the inhibition tests for TNF-␣, IL-6 release, and NO secretion. Assays were performed using duplicate cultures. The data are expressed as means Ϯ standard deviations for three replicates.
RESULTS
Bacteria and lipooligosaccharide preparation. B. pertussis strains 186 and 606 and two clinical isolates (strains 3210 and 3225) were used in this study. The lipooligosaccharides of B. pertussis strains were isolated by the water-phenol method and analyzed by SDS-PAGE (Fig. 1A) , which revealed the presence of incomplete LOS in strain 606 (fast-migrating band) and complete LOS in strain 186 (slowly migrating band) and strains 3210 and 3225 (not shown). Using HR-MAS NMR analysis of the intact LOS of B. pertussis strains 186 and 606, the N-methyl and N-acetyl groups present in dodecasaccharide-containing LOS of B. pertussis as described by Le Blay et al. (22) were identified and distinguished directly (Fig. 2) . Therefore, the characteristic N-acetyl and N-methyl resonances in the spectra could be used as structure reporter groups (48) for identification of the complete LOS of B. pertussis.
B. pertussis strain 186, which is used for production of the pertussis cellular vaccine in Poland (Biomed, Krakow, Poland) and has the complete LOS structure as determined by SDS-PAGE and HR-MAS NMR, was chosen for preparation of the pentasaccharide.
Isolation of the pentasaccharide, preparation of the neoglycoconjugate, and reactivity of anticonjugate antibodies. The pentasaccharide was selectively cleaved from LOS of B. pertussis strain 186 by deamination with nitrous acid. The soluble oligosaccharide fraction isolated by ultracentrifugation was purified on a Bio-Gel P-2 column and analyzed by 1 H NMR spectroscopy and MALDI-TOF MS.
The 1 H (Fig. 2) and HSQC-DEPT NMR (see Fig. SA1 Table SA1 in the supplemental material) except those for a 4,6-disubstituted 2,5-anhydroMan residue were the same as those described for the LOS of B. pertussis 1414 (3). However, the MALDI-TOF MS spectrum (Fig. 3) showed that the molecular mass of the isolated pentasaccharide did not match the expected mass (mass difference, 29).
The combined data from the MALDI-TOF spectra of the pentasaccharide and HR-MAS NMR experiments performed for the LOS suggested that the amino group at C-4 of the 33)-␤-L-FucpNAc4NMe-(13 methylated in the native LOS was also nitrosylated, forming an N-nitroso compound during the deamination procedure. This observation was confirmed by the lack of pH dependence of the N-methyl resonance chemical shift (␦ H 3.26 ppm) in the pentasaccharide.
The MALDI-TOF mass spectrum of the oligosaccharide (Fig. 3) had a main ion at m/z 1068.0, corresponding to the pentasaccharide as [MϩNa] ϩ consisting of one GlcNAc, one Hep, one Man2NAc3NAcA, one 2,5-anhydroMan, and one FucNAc4NRMe with an N-methyl group nitrosylated (R) during the deamination procedure.
A single aldehyde group in the pentasaccharide (Fig. 2) , which was formed during the deamination procedure, was used to form the covalent linkage with a monomeric fraction of tetanus toxoid by reductive amination (17) . The neoglycoconjugate obtained was used for immunization of rabbits (four animals). The reactivities of antipentasaccharide-TT conjugate antibodies with the dodecasaccharide-containing LOS of homologous B. pertussis strain 186 and the nonasaccharide-containing LOS of strain 606 were determined by immunoblotting and by an ELISA. The antibodies reacted strongly, at both high and low concentrations, with LOS of strain 186 in the ELISA (Fig. 1) . However, they showed only weak reactions at a high concentration with LOS of strain 606, suggesting that the binding epitope is located in the distal trisaccharide, which occurs only in the LOS with a complete dodecasaccharide. The antisera obtained from different animals showed similar antibody reaction patterns with the LOS of strains 186 and 606 (Fig. 1) , and one of them was used for a detailed analysis by STD NMR and the immunochemical and biological methods. The level of antipentasaccharide antibodies of the IgG class was determined by the quantitative microprecipitin test. At the equivalence point the LOS of B. pertussis strain 186 precipitated 1.5 mg of antibody per ml of serum.
The reactivities of antipentasaccharide-TT conjugate antibodies with LOS of different B. pertussis strains were also tested by immunoblotting of antigens separated by SDS-PAGE. The antibodies reacted strongly with the slowly migrating LOS fraction of strain 186, but no reaction was observed with the fast-migrating fraction (devoid of the distal trisaccharide) of strain 606 (Fig. 1B) . The reactions observed were in agreement with the data obtained by the ELISA.
The binding of anticonjugate antibodies and antibodies (Fig. 4A) . A similar pattern was observed for the reactions of the anticonjugate antibodies with heat-killed cells of clinical isolates 3210 (Fig. 4B) and 3225 (Fig. 4C) . FACS analysis carried out with live and heat-killed bacteria showed that the anticonjugate antibodies labeled with high intensity more than 95% of the bacterial cells counted. Mapping of the binding epitope within the pentasaccharide by saturation transfer difference NMR experiments. The reactions of anticonjugate antibodies with dodecasaccharidecontaining LOS of B. pertussis observed in the ELISA and immunoblotting assays suggested that the binding epitope is localized within the pentasaccharide which was investigated. Therefore, the structural elements within the pentasaccharide that could contribute to the binding epitope were investigated by STD NMR (30, 32) STD NMR experiments confirmed that the immunodominant epitope recognized by the anticonjugate antibodies is located predominantly in the distal trisaccharide of B. pertussis 186 LOS.
Inhibition of LOS induced TNF-␣ and IL-6 secretion. The J774A.1 cells stimulated with LOS of B. pertussis strain 186 released TNF-␣ and IL-6 in a dose-response mode. The concentrations of TNF-␣ and IL-6 in the supernatants were calculated from the calibration curves for mouse recombinant TNF-␣ and recombinant IL-6, respectively. The anticonjugate antibodies at a concentration of 150 g/ml inhibited the secretion of TNF-␣ by LOS-induced J774A.1 cells so that the level was almost the same as the level detected in the supernatant of nonstimulated cells. There was a 10-fold decrease in both the TNF-␣ and IL-6 levels ( Fig. 5 ) compared to the levels determined for the supernatants of the J774A.1 cells stimulated with the preimmune antibodies used for inhibition.
Inhibition of LOS induced NO release. The NO secretion by J774A.1 cells stimulated with LOS of B. pertussis strain 186 (10 ng/ml) was determined by determining the total nitrite by the colorimetric assay using the Griess reagent. The preimmune antibodies were used as the control for inhibition of NO production. A threefold reduction in the nitrite concentration in the supernatants of J774A.1 cells was observed when the antipentasaccharide-TT conjugate antibodies (150 g/ml) were used for inhibition of NO production by LOS-induced J774A.1 cells (Fig. 5) .
DISCUSSION
LPS is a major component of the cell membrane of gramnegative bacteria, is the most exposed antigen in nonencapsulated bacteria, is an important virulence factor, and is the target for specific antibodies (39) . It is well known that protective human immunity to many gram-negative diseases correlates with the presence of serum bactericidal antibodies that recognize surface carbohydrate antigens (20) .
Therefore, the conclusion reached in the study of Chaby and Caroff (5) which suggested that endotoxin is not very important in the pertussis syndrome in humans seemed to be unlikely and not fully supported by experimental data. Contrary evidence, presented by Flak and Goldman (8) , indicated that B. pertussis endotoxin plays a crucial role in the selective destruction of the ciliated cells of human airway mucosa. In this process the endotoxin works synergistically with tracheal cytotoxin by inducing a toxic level of NO released from secretory epithelial cells. In addition, the exposure of humans to B. pertussis during infection can induce an immune response against LOS, the main surface antigen of this bacterium (44) . However, these molecules in a free form or present on bacterial cells are toxic, reactogenic, T-independent antigens. It was found that in some cases LOS can stimulate the production of bactericidal antibodies even if it is present on bacteria in the form of Tindependent antigen (51) . The carbohydrate component of LPS, when linked to a protein carrier, becomes a nontoxic, highly immunogenic, T-dependent antigen (18, 24) .
We demonstrated previously that covalent conjugates of oli-gosaccharides with tetanus toxoid were immunogenic and induced specific antibodies belonging to the IgG class in animals. The antibodies produced against complete core structures of Escherichia coli reacted strongly with LPS in the presence of serum proteins and were able to recognize LPS present on the surface of live bacteria (25, 26, 28) .
Here we determined the structural details of the pentasac- charide isolated from the LOS of B. pertussis strain 186 and examined the specificity and the endotoxin-neutralizing activity of antibodies against a neoglycoconjugate of the pentasaccharide with tetanus toxoid. The anticonjugate antibodies reacted specifically with the wild-type LOS of B. pertussis and substantially reduced its ability to activate J774A.1 cells for production of NO, TNF-␣, and IL-6. These antibodies were able to react with the isolated LOS in the presence of serum proteins, as well as with LOS present on the surface of live bacteria. The reactivities of the monospecific antibodies against the neoglycoconjugate of a single antigen (i.e., the LOS pentasaccharide) and the antibodies raised against the whole bacteria (i.e., antibodies against a variety of bacterial surface antigens exposed on the surface of B. pertussis cells) were similar. These data confirm the importance of a proper form of antigen used for immunization. The STD NMR experiments used for the interaction studies demonstrated that the immunodominant epitope recognized by the anticonjugate antibodies within the pentasaccharide is located predominantly in the distal trisaccharide. The data are in agreement with previous observations of Le Blay et al. (22) concerning the specificities of three different monoclonal antibodies against B. pertussis LOS. These antibodies recognized three distinct epitopes in the distal pentasaccharide of the B. pertussis LOS, (i) the terminal ␣-D-GlcpNAc- (13, We believe that such a specific antibody directed against the terminal trisaccharide could compensate for the lack of SP-A interaction with B. pertussis LOS in vivo and promote agglutination, phagocytosis, and bacterial killing, as well as inhibition of the endotoxic activity of the LOS.
Weiss and coworkers screened a set of human immune sera to identify the antibodies which can promote killing of B. pertussis cells (51) . They found that antibodies to the B. pertussis LOS, in the presence of complement, could be bactericidal against wild bacterial strains producing BrkA protein, a virulence factor which inhibits the classical pathway of complement activation (2). However, not all anti-LOS antibodies were bactericidal. Antibodies produced against the components of acellular pertussis vaccine, which is devoid of LOS, did not promote the complement-dependent killing of bacteria.
Thus, finding a simple method for distinguishing between protective and nonprotective immune responses to B. pertussis infection and defining the additional components of acellular pertussis vaccine seem to be very important. We anticipate that doing these things could improve the efficiency of the vaccine by promoting the immune defense that can kill bacteria and neutralize the harmful effects of endotoxin.
